Analyst Price Targets — BTAI
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| September 23, 2024 7:04 am | Graig Suvannavejh | Mizuho Securities | $1.00 | $0.59 | StreetInsider | Mizuho Reiterates Neutral Rating on BioXcel Therapeutics (BTAI) |
| April 15, 2024 6:44 am | Raghuram Selvaraju | H.C. Wainwright | $10.00 | $2.90 | StreetInsider | BioXcel Therapeutics (BTAI) PT Lowered to $10 at H.C. Wainwright |
| August 15, 2023 2:02 pm | Graig Suvannavejh | Mizuho Securities | $4.00 | $3.98 | Benzinga | Challenging Horizon For BioXcel: Analysts Dive Into Igalmi's Potential And Reshaped Commercialization Strategy |
| January 3, 2023 6:12 am | — | H.C. Wainwright | $73.00 | $21.48 | Benzinga | HC Wainwright & Co. Maintains Buy on BioXcel Therapeutics, Lowers Price Target to $73 |
| November 11, 2022 8:50 am | — | Guggenheim | $25.00 | $14.82 | Benzinga | Guggenheim Maintains Buy on BioXcel Therapeutics, Lowers Price Target to $25 |
Latest News for BTAI
BioXcel Therapeutics intends to complete a court-supervised sale transaction, in an effort to maximize value for all stakeholders Teva Pharmaceuticals to serve as “stalking horse” bidder in a court-supervised 363 auction process BioXcel Therapeutics has secured a commitment for debtor-in-possession (DIP) financing to support ongoing operations NEW HAVEN, Conn., Aug. 28, 2026 (GLOBE NEWSWIRE) -- BioXcel Therapeutics,…
AI-driven biopharma firm BioXcel Therapeutics filed for Chapter 11 bankruptcy protection in the U.S. on Thursday.
BioXcel Therapeutics, Inc. (BTAI) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to a loss of $2.45 per share a year ago.
Shares of BioXcel Therapeutics, Inc. (NASDAQ: BTAI - Get Free Report) have received an average recommendation of "Hold" from the four ratings firms that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and two have given a buy recommendation
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for BTAI.
U.S. House Trading
No House trades found for BTAI.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.